AddressPosted Date: Mar 8 2024
Associate Director - Epidemiology
The Associate Director in Epidemiology will support the development of asset or disease specific epidemiology strategy and providing scientific leadership in the application of epidemiological expertise and methods to inform internal and external decision-making across all phases of medicine development to increase efficiency and effectiveness of delivering medicines to patients.
This position functions within the Epidemiology Department, which contributes to the successful development of new medicines. Our staff in Epidemiology provide leadership and expertise to develop and execute the Epidemiology strategy across the entire spectrum of drug development, from early discovery to registration and lifecycle management.
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.
We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.
Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK
In this role you will
- Maintain and expand an epidemiology support strategy aligned with the medicine development strategy, utilizing your expertise in epidemiology and the disease area.
- Improve disease understanding relevant to medicine development, including but not limited to: incidence, prevalence, risk factors, natural history course, treatment patterns, co-morbidities, co-medications/vaccinations, outcome measures, serotypes, biomarkers, unmet needs, and their variations across demographics and geographies.
- Support and be accountable for advising scientifically on Real World Evidence strategies.
- Contribute to medication safety evaluation by providing background event rates, synthesizing existing evidence including through meta-analyses, and identifying high-risk populations.
- Propose and lead post-marketing activities, including risk evaluation mitigation strategies, epidemiology studies for signal detection and inference, and post-authorization studies supporting benefit/risk evaluation.
- Critically appraise existing epidemiology evidence and generate new evidence through delivery of specific research plans/protocols and analysis of healthcare databases available within GSK.
- Develop strong partnerships with internal stakeholders in a multi-disciplinary framework (clinical, safety, regulatory, health outcomes, asset leadership) to meet product needs.
- Plan resource allocation to accomplish multiple research projects and attain project and study timelines.
- Identify innovative, timely, and cost-effective methods to conduct epidemiologic studies.
- Propose and negotiate the content of epidemiologic strategy and budget with matrix leaders.
- Communicate study findings effectively to relevant internal and external audiences.
- Provide input into regulatory submission documents and represent the function to regulatory agencies as required.
- Participate in departmental initiatives aimed at driving innovative solutions through evaluation and creation of tools, methodologies, or processes.
- May contribute to advancing the science through membership or leadership of external initiatives (e.g., ICPE, IMI).
Why you?
Basic Qualifications & Skills:
We are looking for professionals with these required skills to achieve our goals:
- Doctoral degree (PhD., ScD or DrPH) in epidemiology (preferred) or a relevant discipline (i.e., health services research, health outcomes research, public health, statistics, or pharmaceutical sciences)
- At least one year experience conducting pharmacoepidemiologic research in the pharmaceutical industry or equivalent experience in an academic or government setting.
- Excellent oral and written communication skills and demonstrated ability to communicate scientific evidence to peers and at scientific meetings.
Preferred Qualifications & Skills:
Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:
- Expertise in infectious disease epidemiology
- Self-motivated with the ability to work independently to develop credibility with colleagues within and outside Epidemiology, as well as interact effectively in multi-disciplinary matrix teams to influence decisions.
- Broad experience in collaborating with research partners
- Problem-solver; ability to see solutions to complex, unique situations where the epidemiological principles need to be applied.
- Ability to work well within a global and matrix environment, balance priorities, and handle multiple tasks through good planning, project administration, and organization skills.
- Ability to relay complex, technical information from real world studies to cross-functional teams, stakeholders, and non-technical audiences
- Excellent understanding of the pharmaceutical environment across multiple countries/regions
- Experience in leading epidemiology research in US, EU, and Asia-Pacific
- Agile and distributed decision-making – using evidence and applying judgement to balance pace, rigor and risk.
- Managing individual and team performance.
Closing Date for Applications – 24th March 2024 (COB)
Please take a copy of the Job Description, as this will not be available post closure of the advert.
When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.
Why Us?
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Ukdiversity.recruitment@gsk.com or 0808 234 4391.
Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a UK Recruitment FAQ guide. Click the link and scroll to the Careers Section where you will find answers to multiple questions we receive
As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.
We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.
